Jundishapur Journal of Microbiology

Published by: Kowsar

Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase

Manoochehr Makvandi 1 , 2 , 3 , * , Niloofar Neisi 3 , Davod Khalafkhany 3 , Kamyar Makvandi 4 , Eskandar Hajiani 5 , Ali Akbar Shayesteh 5 , Abdolrahim Masjedi Zadeh 5 , Amir Hosein Sina 6 , Mojtaba Hamidifard 3 , Mojtaba Rasti 3 , Ehsan Aryan 7 , Kambiz Ahmadi 8 and Mohammad Jafar Yad Yad 9
Authors Information
1 Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Virology Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Gastroenterology and Hepatology Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Pathology Unit, Danesh Laboratory, Tehran, IR Iran
7 Antimicrobial Resistance Research Center, Department of Medical Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
8 Department of Statistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
9 Department of Education Development Center, Ahvaz Jundishapur of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2014, 7 (8); e11648
  • Published Online: July 13, 2014
  • Article Type: Research Article
  • Received: April 19, 2013
  • Revised: June 25, 2013
  • Accepted: July 14, 2013
  • DOI: 10.5812/jjm.11648

To Cite: Makvandi M, Neisi N, Khalafkhany D, Makvandi K, Hajiani E, et al. Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase, Jundishapur J Microbiol. 2014 ; 7(8):e11648. doi: 10.5812/jjm.11648.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002; 2(7): 395-403[PubMed]
  • 3. Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010; 108: 21-72[DOI][PubMed]
  • 4. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 5. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 6. Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari S, Somi MH, et al. An economic analysis of premarriage prevention of hepatitis B transmission in Iran. BMC Infect Dis. 2004; 4: 31[DOI][PubMed]
  • 7. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 8. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol. 2007; 13(1): 14-21[PubMed]
  • 9. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004; 47(6): 289-309[DOI][PubMed]
  • 10. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances. J Gastroenterol Hepatol. 2011; 26 Suppl 1: 123-30[DOI][PubMed]
  • 11. Phung TB, Alestig E, Nguyen TL, Hannoun C, Lindh M. Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam--genotypes B4 and C1 predominate. J Med Virol. 2010; 82(8): 1327-33[DOI][PubMed]
  • 12. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 13. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 14. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004; 127(5): 1356-71[PubMed]
  • 15. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002; 9(4): 243-57[PubMed]
  • 16. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007; 46(1): 160-70[DOI][PubMed]
  • 17. Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut. 2000; 47(3): 429-35[PubMed]
  • 18. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 19. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005; 34 Suppl 1-21[PubMed]
  • 20. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, et al. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat. 2009; 16(6): 437-43[DOI][PubMed]
  • 21. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012; 25(1): 142-63[DOI][PubMed]
  • 22. Shavakhi A, Norinayer B, Esteghamat FS, Seghatoleslami M, Khodadustan M, Somi MH, et al. Occult hepatitis B among Iranian hepatitis C patients. J Res Med Sci. 2009; 14(1): 13-7[PubMed]
  • 23. Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013; 12(2): 213-9[PubMed]
  • 24. Arababadi MK, Pourfath EM, Jafarzadeh A, Hasanshahi GH, Afrouz M, Hadadian M. Occult HBV infection in Rafsanjanese blood donors. Modares J Med Sci . 2008;
  • 25. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Da Silva LC, Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol. 2004; 42(6): 2455-60[DOI][PubMed]
  • 26. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology. 2000; 31(2): 488-95[DOI][PubMed]
  • 27. Raimondo G, Pollicino T, Romano L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010; 58(4): 254-7[DOI][PubMed]
  • 28. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, et al. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol. 2009; 24(4): 588-98[DOI][PubMed]
  • 29. Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, et al. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol. 2006; 78(9): 1164-74[DOI][PubMed]
  • 30. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis. 2009; 13(6): 685-9[DOI][PubMed]
  • 31. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F, Sabouri E, et al. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol. 2006; 78(3): 358-64[DOI][PubMed]
  • 32. Alfaresi M, Elkoush A, Alshehhi H, Alzaabi A, Islam A. Hepatitis B virus genotypes and precore and core mutants in UAE patients. Virol J. 2010; 7: 160[DOI][PubMed]
  • 33. Ali M, Idrees M, Ali L, Hussain A, Ur Rehman I, Saleem S, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011; 8: 102[DOI][PubMed]
  • 34. Jain P, Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J Gastroenterol. 2008; 14(14): 2288-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments